Spelling suggestions: "subject:"guérison""
1 |
Vacina terapêutica: avaliação de Mycobacterium bovis BCG recombinante para imunoterapia de câncer superficial de bexiga / Vacina terapêutica: avaliação de Mycobacterium bovis BCG recombinante para imunoterapia de câncer superficial de bexigaBegnini, Karine Rech 15 February 2012 (has links)
Made available in DSpace on 2014-08-20T13:32:48Z (GMT). No. of bitstreams: 1
dissertacao_karine_begnini.pdf: 1622668 bytes, checksum: 238f06c82a5dce8f22542c15f37944f4 (MD5)
Previous issue date: 2012-02-15 / Bacillus Calmette-Guerin (BCG) is one of the great success stories of immunotherapy as a treatment for superficial urothelial carcinoma of the bladder. The high incidence of local side effects and presence of non-responder diseases has led to efforts to improve the therapeutic vaccine. Hence, we proposed that an auxotrophic recombinant BCG strain overexpressing Ag85B (BCG ΔleuD/Ag85B), could enhance cytotoxicity to the human bladder carcinoma cell line (5637). This rBCG was generated by incorporating an expression plasmid encoding the mycobacterial antigen Ag85B into the BCG ΔleuD strain. The inhibitory effect of BCG ΔleuD/Ag85B in 5637 cells was determined by the MTT method, morphology observation and the LIVE/DEAD assay. Gene expression profiles for apoptotic genes, cell cycle-related genes and oxidative stress-related genes were investigated by qRT-PCR. Bax, bcl-2 and p53 induction by BCG ΔleuD/Ag85B treatment were evaluated by Western blotting. BCG ΔleuD/Ag85B revealed a superior cytotoxicity effect than the strains used as controls in this study. The results demonstrated that the expression level of pro-apoptotic and cell cycle-related genes increased after BCG ΔleuD/Ag85B treatment, whereas mRNA levels of antiapoptotic genes decreased. Interestingly, BCG ΔleuD/Ag85B also increased the mRNA level of antioxidant enzymes in bladder cancer cell line. Bax and p53 protein levels were increased by BCG ΔleuD/Ag85B treatment. In conclusion, these results suggested that BCG ΔleuD/Ag85B enhanced cytotoxicity on superficial bladder cancer cells in vitro. The therapeutic model using rBCG may have potential for future clinical application in the treatment of bladder cancer. / O Bacilo Calmette-Guérin (BCG) constitui uma das grandes histórias de sucesso da imunoterapia como tratamento para carcinoma superficial da bexiga. Porém, a alta incidência de efeitos colaterais locais e a ocorrência de tumores resistentes ao tratamento têm impulsionado estudos visando melhorias da vacina terapêutica. Neste trabalho, propusemos que uma cepa auxotrófica de BCG superexpressando o antígeno Ag85B (BCG ΔleuD/Ag85B), é capaz de aumentar a citotoxicidade na linhagem celular humana de carcinoma superficial de bexiga (5637). A cepa de BCG recombinante foi gerada através da incorporação da sequencia do antígeno Ag85B em um plasmídeo de expressão micobacteriano na cepa de BCG ΔleuD. O efeito inibitório do BCGΔleuD/Ag85B em células 5637 foi determinada através das técnicas colorimétricas MTT e LIVE/DEAD, além de observação morfológica. Os perfis de expressão gênica para genes apoptóticos, genes relacionados ao ciclo celular e genes de estresse oxidativo foram avaliados por qRT-PCR. Os níveis protéicos de bax, bcl-2 e p53 foram avaliados por western blot. O BCG ΔleuD/Ag85B revelou citotoxicidade superior às cepas utilizadas como controle neste estudo. Os resultados obtidos demonstram níveis superiores de expressão de genes pró-apoptóticos e de genes relacionados com o ciclo celular após tratamento com BCG ΔleuD/Ag85B. Níveis inferiores de mRNA de genes antiapoptóticos foram detectados após o mesmo tratamento. Ainda, o tratamento com BCG ΔleuD/Ag85B também elevou os níveis de mRNA de enzimas antioxidantes em linhagem de células de câncer superficial de bexiga. As proteínas Bax e p53 mostraram-se elevadas após tratamento com BCG ΔleuD/Ag85B. Em conclusão, estes resultados sugerem que a cepa de BCG superexpressando Ag85B é capaz de aumentar a citotoxicidade sobre as células de câncer superficial de bexiga in vitro. Este modelo terapêutico usando BCG recombinante possui potencial para uma futura aplicação clínica em tratamento de câncer de bexiga.
|
2 |
Search for Surrogate Marker(s) of Immunity Following Vaccination with Experimental Vaccine (Autoclaved Leishmania Major + Bacille Calmette-Guérin) in Human VolunteersMahmoodi, Majid 12 1900 (has links)
Cutaneous leishmaniasis (CL) is usually a self-limiting lesion on the skin while visceral leishmaniasis is a progressive, systemic disease with high mortality even if treated. The problem associated with treatment and vector control justifies a search for an effective vaccine which seems to be the only practical means to control the disease. The aim of this study is to identify immunological surrogate marker(s) associated with protection against Leishmania infection. The results indicate that a single dose of ALM+BCG induced Thl-like response but the level of such response is not sufficient for full protection. Accordingly, further evaluation of the vaccine is necessary other strategies multiple injections or changing the adjutant.
|
3 |
Avaliação da eficácia da Vacina BCG na mortalidade por causas específicas.Andrade, Kleydson Bonfim 26 May 2015 (has links)
Submitted by Maria Creuza Silva (mariakreuza@yahoo.com.br) on 2016-04-14T18:12:50Z
No. of bitstreams: 1
Dissertacao. Kleydson Bonfim Andrade.2015.pdf: 654797 bytes, checksum: 1ff7694eaf3e0bcfb880b2d0518bf2c9 (MD5) / Approved for entry into archive by Maria Creuza Silva (mariakreuza@yahoo.com.br) on 2016-04-18T12:52:53Z (GMT) No. of bitstreams: 1
Dissertacao. Kleydson Bonfim Andrade.2015.pdf: 654797 bytes, checksum: 1ff7694eaf3e0bcfb880b2d0518bf2c9 (MD5) / Made available in DSpace on 2016-04-18T12:52:53Z (GMT). No. of bitstreams: 1
Dissertacao. Kleydson Bonfim Andrade.2015.pdf: 654797 bytes, checksum: 1ff7694eaf3e0bcfb880b2d0518bf2c9 (MD5) / Vários estudos demonstram efeito protetor da vacina BCG, 1 dose ao nascer, contra tuberculose, variando de 70-86%. Outros estudos demonstram efeitos inespecíficos da BCG, 1ª dose, na redução em 17% da mortalidade geral, com efeitos maiores no período neonatal. Objetivou-se com esse estudo, verificar o efeito da vacina BCG, 1ª dose neonatal e na infância, na mortalidade geral, nas cidades de Salvador-BA e Manaus-AM. Trata-se de um ensaio comunitário controlado e randomizado, sem placebo, acontecido entre 1996-1998 (REVAC-BCG). Escolas públicas de Salvador e Manaus com crianças de 7-14anos foram randomizadas para vacinação com BCG (2ª dose). Os registros compuseram um banco de dados com 354.406 crianças. Utilizando o software RecLink III, foi realizado o linkage probabilístico com todos os óbitos registrados no Sistema de Informação em Mortalidade, ocorridos nas duas capitais entre os anos de 1997 e 2014. Para a comparação entre os grupos (intervenção e controle), foi feira a estatística descritiva, incluindo o cálculo da Taxa de Mortalidade e a Razão da Taxa de Mortalidade. Para a estimativa da Efetividade Vacinal, foi utilizada a Regressão Logística com GEE, e para Análise de Sobrevida, foram calculadas as estimações não-paramétricas de Kaplan-Meier. Foi observada uma distribuição semelhante das variáveis (sexo, faixa etária e status socioeconômico) entre os grupos intervenção e controle, tanto no grupo de análise da primeira dose neonatal quanto na primeira dose na infância. Os achados apontam para um efeito protetor da vacinação por BCG neonatal na mortalidade geral de 25%, e da vacinação por 1ª dose de BCG na infância de 10%. Este é o primeiro estudo no Brasil que buscou avaliar o efeito de vacinas na mortalidade e, corroborando com outros estudos, os resultados demonstram que a vacina BCG neonatal é uma medida eficaz na redução de óbitos.
|
4 |
Les relations scientifiques entre la France et le Japon à travers l'avènement de la bactériologie par la tuberculose et le BCG (1898-1955)Osseyrane, Léa January 2009 (has links)
Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.
|
5 |
Les relations scientifiques entre la France et le Japon à travers l'avènement de la bactériologie par la tuberculose et le BCG (1898-1955)Osseyrane, Léa January 2009 (has links)
Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal
|
6 |
La lettre comme lieu d’invention d’un destin littéraire : le cas de Félicité Angers (Laure Conan)Savoie, Marie-Pier 23 April 2018 (has links)
Félicité Angers, mieux connue sous son pseudonyme de Laure Conan, est la première Canadienne française à vivre de sa plume. Sa correspondance, d’abord recueillie et annotée par Jean-Noël Dion en 2002 sous le titre J’ai tant de sujets de désespoir, puis complétée par la découverte de douze autres lettres parues en 2007 dans l’édition critique d’Angéline de Montbrun préparée par Nicole Bourbonnais, est constituée aujourd’hui de 362 lettres qui demeurent le seul matériau par lequel nous avons accès à l’intimité de l’écrivaine. Nous pourrons donc saisir son parcours par le biais de cet élan qu’est la pratique de l’écriture épistolaire en sillonnant ses lettres intimes, empreintes d’une sensibilité qui lui est propre, tout autant que ses lettres professionnelles, qui témoignent du processus de son émancipation littéraire. Cette correspondance nous permettra également, en dernière partie, de lever le voile sur les influences féminines de l’écrivaine.
|
7 |
Bioresponsive liposomes to target drug release in alveolar macrophagesHopkinson, Devan January 2017 (has links)
Tuberculosis is one of the most prevalent infectious diseases globally due to the successful survival mechanisms displayed by Mycobacterium tuberculosis (Mtb). Mtb primarily infects alveolar macrophages (AMs) and is able to live intracellularly for extended periods of time due to a number of virulence factors which inhibit the antibacterial mechanisms of the AMs. This aspect of the Mtb life cycle means TB treatments suffer from poor bioavailability and efficacy. Additionally, the rise in resistant strains of Mtb means the use of higher doses and the use of alternative second and third line drugs which increase the risk of systemic toxicity. Drug encapsulation is a novel approach that can provide more favourable drug pharmacokinetics and pharmacodynamics. The aim of this project was to develop a liposomal drug delivery system to target Mtb infected alveolar macrophages. The system involved the encapsulation of two drugs; the antibiotic gatifloxacin (GFLX) and Mtb virulence factor inhibitor CV7. The hypothesis was that the two different antibacterial mechanisms would work in synergy and increase the efficacy of the treatment. AM targeting and receptor-mediated endocytic uptake was encouraged by the presence of a ligand attached to the surface of the liposome. Furthermore a pH-sensitive release mechanism was to be incorporated into the liposome to encourage the release of the encapsulated drugs in the vicinity of the intracellular bacteria. The intention was to produce a drug delivery system to enable a TB therapy regime of fewer, lower doses to increase compliance and reduce systemic toxicity by increasing efficacy through improved bioavailability. GFLX was successfully encapsulated using a weak base active loading method. To establish encapsulation efficiency, a homogeneous fluorescence assay able to quantify intra- and extra-liposomal gatifloxacin simultaneously was developed. pH-sensitive release of the payload could be achieved using a pH-sensitive peptide with a novel design based on chimeric structure, namely P3. CV7 was successfully encapsulated using a weak acid active loading method. CV7 liposomes were able to be functionalised by the incorporation of a mannose ligand on the surface of the liposome. An inhibition assay using the target enzyme of CV7, MptpB, was optimised to assess efficacy of liposomally encapsulated and released CV7. Flow cytometry and confocal microscopy studies confirmed that the liposomal formulations were internalised by the target macrophage cell line, J774a.1. Mannose liposomes conveyed superior uptake kinetics. Further confocal microscopy showed that after internalisation the liposomes entered the endolysosomal pathway and colocalised with BCG. A BCG-macrophage infection model was used to determine the intracellular efficacy of the liposomal formulations. Encapsulated CV7 displayed increased efficacy over free CV7, while encapsulation in functionalised liposomes showed better efficacy still. The encapsulation of GFLX did not increase the efficacy of GFLX and synergy between the two drugs was not achieved. In conclusion, the liposomal encapsulation of CV7 increased uptake of the drug by the target cell line and facilitated colocalisation of the drug with the target pathogen thereby increasing efficacy. Such a formulation could potentially increase bioavailability and efficacy in vivo for a more tolerable TB therapy.
|
8 |
Lisování prolisů v austenitickém nerezavějícím plechu / Pressing punches on austenitic stainless sheetRudolf, Bronislav January 2012 (has links)
Thesis resolvs proposal punches in the sheet metal for heat transfer solar panels. Shapes of punches are selected – piramidal shape and lengwise shape. It is reviewed their possible production and the selected method of Guérin is described. Sheet metal from austenitic stainless 17 240 is selected for the manufacturing. Forming tool is designed with interchangeable punches and elastic medium for various modifications and comparing shapes of punches. It is used hydraulic press CZR 600 for a experimental production.
|
9 |
The evaluation of whole blood cytokine assay for diagnosis of M.tuberculosis infection in South African children with household tuberculosis contact.Masilo, J. M. 04 1900 (has links)
M. Tech. (Department of Biotechnology, Faculty of Applied and Computer Sciences), Vaal University of Technology. / Background: There are critical unmet needs for improved strategies in the detection
and diagnosis of M.tuberculosis infection in children, and for prevention of
tuberculosis disease in children. Bacillus Calmette-Guérin (BCG) vaccination has
limited the utility of tuberculin skin testing (TST) in areas with high vaccine coverage.
Objectives: The aim of this study was to estimate the prevalence of M.tuberculosis
infection in children with household tuberculosis contacts, using QFT-GIT testing in
comparison with TST.
Methods: This study was a cross-sectional design to assess the performance of a
new T-cell based blood test, namely QuantiFERON-TB Gold In Tube (QFT-GIT), for
diagnosis of tuberculosis infection in the children (n=182) of adults (n=124) with
pulmonary tuberculosis, additionally to determine the prevalence of M.tuberculosis
infection in children with household tuberculosis contacts, using QFT-GIT testing in
comparison with TST. The study was carried out at Chris Hani Hospital. For children
involved in the study, tuberculosis exposure information was obtained, together with
TST, QFT-GIT, and HIV testing.
Data obtained from both experiments was statistically analysed using SPSS version
24 to determine whether there was a significant agreement between QFT-GIT and
TST on the detection of M.tuberculosis prevalence in children with house hold
contacts with confirmed M.tuberculosis infection.
Results: This study examined the sensitivity and specificity of the QFT-GIT tests
compared with the standard TST for diagnosing latent tuberculosis disease in
paediatric contacts. Because of the lack of a latent tuberculosis “gold standard”, the
specificity and sensitivity of QFT-GIT was calculated with a two-by-two table method.
The specificity of the QFT-GIT was 84% and the sensitivity was 85%. There was a
good correlation between QFT-GIT and TST (Cohen’s kappa of 0.705). Seventeen
percent (17%) of the 182 children tested by QFT-GIT yielded indeterminate results.
Age was associated with indeterminate QFT-GIT results in paediatric tuberculosis
contacts. Point prevalence for QFT-GIT was recorded as 31% at baseline and 39.5%
after six months indicating variability between QFT-GIT results at baseline and after
six months.
Conclusion: It was concluded that the prevalence of tuberculosis infection was
common among South African children who live with an adult with active
tuberculosis. The agreement between QFT-GIT assay and TST for the diagnosis of
latent tuberculosis in children was high. Although TST and QFT-GIT assays
appeared comparable, QFT-GIT showed higher positivity rate amongst those
contacts with reported household tuberculosis exposure compared to TST. The QFTGIT
assay was a better indicator of the risk of M.tuberculosis infection than TST in a
BCG-vaccinated population.
|
10 |
Une littérature qui ne passe pas. Récits de captivité des prisonniers de guerre français de la Seconde Guerre mondiale (1940-1953)Quinton, Laurent 30 November 2007 (has links) (PDF)
Tout comme les récits de déportation politique et raciale, les récits de captivité des prisonniers de guerre français de la Seconde Guerre mondiale présentent un intérêt non négligeable, du point de vue historique, documentaire, idéologique, mais aussi littéraire.<br />Entre 1940 et 1953, pas moins de 188 récits — témoignages, journaux, romans — furent publiés, qui constituent un corpus riche qui n'a pas été étudié jusqu'à présent. Cette thèse de doctorat entreprend de démêler, à travers l'étude du contexte littéraire et politique de l'époque, les différents enjeux qui gravitent autour de ces récits.
|
Page generated in 0.0624 seconds